Lupin gets one observation from USFDA for Somerset, New Jersey manufacturing facility

The U.S. FDA has conducted a Pre-Approval Inspection at Lupin Ltd's manufacturing facility located in Somerset, New Jersey, U.S.A. The Inspection was conducted from September 29 to October 10, 2025, and concluded with one observation.

We will address the observation and respond to the U.S. FDA within the stipulated timeframe. We are committed to be compliant with CGMP standards across all our facilities.

Shares of Lupin Limited was last trading in BSE at Rs. 1959.70 as compared to the previous close of Rs. 1957.45. The total number of shares traded during the day was 38090 in over 3945 trades.

The stock hit an intraday high of Rs. 1984.00 and intraday low of 1932.30. The net turnover during the day was Rs. 74491114.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 Pharmaceuticals USFDA PreApprovalInspection Somerset NewJersey USA 1Observation